دورية أكاديمية

The mineralocorticoid receptor blocker spironolactone lowers plasma interferon-γ and interleukin-6 in patients with type 2 diabetes and treatment-resistant hypertension.

التفاصيل البيبلوغرافية
العنوان: The mineralocorticoid receptor blocker spironolactone lowers plasma interferon-γ and interleukin-6 in patients with type 2 diabetes and treatment-resistant hypertension.
المؤلفون: Thangaraj, Sai Sindhu, Oxlund, Christina Stolzenburg, Fonseca, Micaella Pereira Da, Svenningsen, Per, Stubbe, Jane, Palarasah, Yaseelan, Ketelhuth, Daniel F.J., Jacobsen, Ib. Abildgaard, Jensen, Boye L.
المصدر: Journal of Hypertension; Jan2022, Vol. 40 Issue 1, p153-162, 10p
قاعدة البيانات: Complementary Index
الوصف
تدمد:02636352
DOI:10.1097/HJH.0000000000002990